# divalproex sodium

NDC: 0615-8586
Generic name: divalproex sodium
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20240626

FDA application: ANDA078853

## Active ingredients

- DIVALPROEX SODIUM: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8586"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8586
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f936b9d0-a58f-4fa5-8db9-752dabb837a6